Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals Shares Homepage, Bse Sensex,NSE Nifty,Latest Prices,Live News,Gainers Losersd,Top Performer,Market Commentry,Live Quotes,Bulk Deals
myirislogo
26 September, 2025 16:08 IST
Earnings
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 24.08 42.49
Tata Stl 136.10 30.24
Ong Corp 255.50 95.26
I T C Lt 439.00 28.72
Ntpc Ltd 318.20 88.67
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
Market Pulse
Leaders
Laggards
FII Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Quotes
Charts
Financials
Recent News
Broker Research
Research
Research Reports
Beryl Drugs Limited
Pharmaceuticals - Formulations
BSE:524606NSE:NABloomberg:BRD@INReuters:BERD.BO
Market Lot: 1Face Value: 10ISIN Demat: INE415H01017
QuotesChartsFinancialsResearchRecent News
MF HoldingBSE/NSE Notices
Company Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 06-JAN-24
Compliance-57 (5) : intimation after the end of quarter 06-JAN-24
Closure of Trading Window 01-JAN-24
Announcement under Regulation 30 (LODR)-Newspaper Publication 09-NOV-23
Closure of Trading Window 30-SEP-23
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 22-SEP-23
PROCEEDINGS OF 30TH ANNUAL GENERAL MEETING 21-SEP-23
Shareholder Meeting / Postal Ballot-Outcome of AGM 21-SEP-23
Announcement under Regulation 30 (LODR)-Newspaper Publication 29-AUG-23
Reg. 34 (1) Annual Report. 28-AUG-23
Corporate Announcement/Information Pursuant To Regulation 44 Of The SEBI (LODR) Regulations, 2015 Regarding Providing Remote E-Voting Facilities For The 30TH Annual General Meeting To Be Held On 21ST September, 2023 25-AUG-23
INTIMATION OF RECORD DATE FOR ANNUAL GENERAL MEETING 25-AUG-23

© All rights reserved. IRIS Business Services Limited
Disclaimer